Abstract
Abstract Metastasis accounts for majority of deaths across cancer types. Tumor microenvironment plays an impotant role in enhancing metastatic propensity of cancer cells. To explore the mechanisms, we herein established a model by in vivo passaging the Lewis lung carcinoma (3LL) cells with 1-2 week of culture in between passages. When injected subcutaneously, 3LL cells have minimal metastasis, while in vivo passaged (p-)3LL cells showed robust metastasis. Sorted p-3LL cells from tumors of the whole body RFP transgenic mice were equally metastatic suggesting that cancer cell intrinsic changes are responsible for the metastatic imprinting. To identify the stromal cell population/s that crosstalk and imprint the metastatic traits in cancer cells, in vivo passages were performed in Rag2-/- mice and WT mice depleted of NK cells that resulted in similar metastatic imprinting excluding the role of adaptive immune and NK cells in this process. Depletion studies in WT mice and/or co-culture of 3LL cells with sorted myeloid cells indicated a critical role for CD11b+Gr1dim myeloid cells in metastatic imprinting. Comparison of gene expression profiles between 3LL and p-3LL cells by microarray showed enhanced expression of claudin-9 in p-3LL cells which was validated at protein levels in mouse and human lung cancers. These results indicate that interaction of CD11b+Gr1dim myeloid cells with cancer cell within tumor microenvironment imprints claudin-9 dependent metastatic traits in cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.